Cargando…

The effect of spike mutations on SARS-CoV-2 neutralization

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines show protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral entry protein, spike. Because new SARS-CoV-2 variants are emerging rapidly, as exemplified by the B.1.1.7, B.1.351,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rees-Spear, Chloe, Muir, Luke, Griffith, Sarah A., Heaney, Judith, Aldon, Yoann, Snitselaar, Jonne L., Thomas, Peter, Graham, Carl, Seow, Jeffrey, Lee, Nayung, Rosa, Annachiara, Roustan, Chloe, Houlihan, Catherine F., Sanders, Rogier W., Gupta, Ravindra K., Cherepanov, Peter, Stauss, Hans J., Nastouli, Eleni, Doores, Katie J., van Gils, Marit J., McCoy, Laura E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2021
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936541/ https://www.ncbi.nlm.nih.gov/pubmed/33713594 http://dx.doi.org/10.1016/j.celrep.2021.108890

Ejemplares similares

Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection
por: Muir, Luke, et al.
Publicado: (2021)

SARS-CoV-2 recruits a haem metabolite to evade antibody immunity
por: Rosa, Annachiara, et al.
Publicado: (2021)

SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
por: Rosa, Annachiara, et al.
Publicado: (2021)

Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021)

Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021)

Influence of IL-6 levels on patient survival in COVID-19
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021)

Vaccine responses in ageing and chronic viral infection
por: Rees-Spear, Chloe, et al.
Publicado: (2021)

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
por: Alrubayyi, Aljawharah, et al.
Publicado: (2021)

SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
por: Jeffery-Smith, Anna, et al.
Publicado: (2022)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
por: Yin, Victor, et al.
Publicado: (2021)

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
por: Graham, Carl, et al.
Publicado: (2021)

A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
por: Seow, Jeffrey, et al.
Publicado: (2022)

Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV
por: Touizer, Emma, et al.
Publicado: (2021)

Sex-Related Differences in Gene Expression by Porcine Aortic Valvular Interstitial Cells
por: McCoy, Chloe M., et al.
Publicado: (2012)

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
por: Graham, Carl, et al.
Publicado: (2021)

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
por: Ng, Kevin W., et al.
Publicado: (2020)

Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
por: Calvaresi, Valeria, et al.
Publicado: (2023)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non–Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae
por: Aldon, Yoann, et al.
Publicado: (2020)

What are the late effects of older gastric cancer survivors? A scoping review
por: Jeon, Misun, et al.
Publicado: (2022)

Persistent Zika Virus Detection in Semen in a Traveler Returning to the United Kingdom from Brazil, 2016
por: Gaskell, Katherine M., et al.
Publicado: (2017)

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
por: Brouwer, Philip J. M., et al.
Publicado: (2020)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022)

Author Correction: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
por: Wrobel, Antoni G., et al.
Publicado: (2020)

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
por: Benton, Donald J., et al.
Publicado: (2020)

To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1
por: Griffith, Sarah A., et al.
Publicado: (2021)

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
por: van Gils, Marit J., et al.
Publicado: (2022)

Computed tomography and [(18)F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates
por: Naninck, Thibaut, et al.
Publicado: (2022)

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections
por: Hellewell, Joel, et al.
Publicado: (2021)

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
por: Wrobel, Antoni G., et al.
Publicado: (2020)

The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2
por: Benton, Donald J., et al.
Publicado: (2021)

Evolution of the SARS-CoV-2 spike protein in the human host
por: Wrobel, Antoni G., et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting
por: Hughes, Ellen C, et al.
Publicado: (2020)

Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
por: Snow, Timothy A.C., et al.
Publicado: (2021)

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
por: Blakney, Anna K., et al.
Publicado: (2019)

An ethical analysis of clinical triage protocols and decision-making frameworks: what do the principles of justice, freedom, and a disability rights approach demand of us?
por: Zhu, Jane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l1p3n1dt04ci56mv3kemvd3842